Korea Investment Corp
ALXN

Korea Investment Corp’s Alexion Pharmaceuticals ALXN Stock Holding History

Korea Investment Corp’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-45,500
Closed -$8.36M – 757
2021
Q2 		$8.36M Sell
45,500
-49,700
-52% -$8.53M 0.02% 430
2021
Q1 		$14.6M Buy
95,200
+32,200
+51% +$4.98M 0.05% 292
2020
Q4 		$9.84M Sell
63,000
-67,791
-52% -$8.71M 0.03% 365
2020
Q3 		$15M Sell
130,791
-22,401
-15% -$2.42M 0.05% 279
2020
Q2 		$17.2M Sell
153,192
-71,300
-32% -$7.57M 0.06% 260
2020
Q1 		$20.2M Buy
224,492
+15,700
+8% +$1.54M 0.09% 214
2019
Q4 		$22.6M Buy
208,792
+25,600
+14% +$2.74M 0.08% 239
2019
Q3 		$17.9M Sell
183,192
-14,200
-7% -$1.6M 0.08% 250
2019
Q2 		$25.9M Sell
197,392
-9,500
-5% -$1.22M 0.11% 206
2019
Q1 		$28M Buy
206,892
+57,890
+39% +$7.2M 0.13% 193
2018
Q4 		$14.5M Buy
149,002
+9,100
+7% +$1.08M 0.08% 263
2018
Q3 		$19.4M Sell
139,902
-8,372
-6% -$1.05M 0.09% 239
2018
Q2 		$18.4M Buy
148,274
+29,700
+25% +$3.47M 0.08% 251
2018
Q1 		$13.2M Buy
118,574
+23,701
+25% +$2.83M 0.06% 288
2017
Q4 		$11.3M Sell
94,873
-12,200
-11% -$1.49M 0.05% 327
2017
Q3 		$15M Sell
107,073
-1,500
-1% -$204K 0.07% 256
2017
Q2 		$13.2M Sell
108,573
-107,979
-50% -$12.6M 0.06% 281
2017
Q1 		$26.3M Sell
216,552
-124,033
-36% -$16M 0.13% 179
2016
Q4 		$41.7M Buy
340,585
+42,665
+14% +$5.22M 0.2% 133
2016
Q3 		$36.5M Buy
297,920
+34,829
+13% +$4.48M 0.19% 144
2016
Q2 		$30.7M Buy
263,091
+14,400
+6% +$2.04M 0.18% 147
2016
Q1 		$34.6M Sell
248,691
-20,100
-7% -$2.95M 0.25% 103
2015
Q4 		$51.3M Buy
268,791
+17,000
+7% +$2.97M 0.36% 59
2015
Q3 		$39.4M Buy
251,791
+53,681
+27% +$9.79M 0.31% 69
2015
Q2 		$35.8M Buy
198,110
+32,200
+19% +$5.56M 0.31% 68
2015
Q1 		$28.8M Buy
165,910
+6,900
+4% +$1.25M 0.22% 110
2014
Q4 		$29.4M Buy
159,010
+11,500
+8% +$2.13M 0.24% 110
2014
Q3 		$24.5M Buy
147,510
+38,610
+35% +$6.34M 0.2% 119
2014
Q2 		$17M Sell
108,900
-1,700
-2% -$268K 0.14% 168
2014
Q1 		$16.8M Buy
110,600
+46,300
+72% +$7.36M 0.15% 162
2013
Q4 		$8.56M Sell
64,300
-11,700
-15% -$1.4M 0.08% 267
2013
Q3 		$8.83M Sell
76,000
-221,100
-74% -$24.3M 0.09% 246
2013
Q2 		$27.4M Buy
+297,100
New +$28.6M 0.33% 68

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Korea Investment Corp's ALXN Position: Q3 2021 in Review

Korea Investment Corp sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 45,500 shares — an estimated $8.36M sold.

Korea Investment Corp first reported a position in ALXN in Q2 2013 and held it in 33 quarters. The position peaked at $51.3M in Q4 2015. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Korea Investment Corp reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Korea Investment Corp sold 45,500 Alexion Pharmaceuticals shares in Q3 2021, an estimated $8.36M.
  • Korea Investment Corp first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 33 quarters.
  • Korea Investment Corp's Alexion Pharmaceuticals position peaked at $51.3M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Korea Investment Corp's 13F filing for Q3 2021, filed 12 Nov 2021.